NAME | CAS |
Factor VII Abnormal Control Level 3
| |
Factor VII Abnormal Control Level 2
| |
Factor VII Abnormal Control Level 1
| |
Factor VII Deficient Plasma
| 7365-45-9 |
1,1-Diethylpropargylamine, 97%
| 3234-64-8 |
Factor V Abnormal Control Level 3
| |
2-Chloro-4-Methylaniline, 98%
| 615-65-6 |
Guanidine acetate
| 593-87-3 |
Factor V Abnormal Control Level 2
| |
Ammonium Sulfobetaine - 22.5 % Solution in Water
| 0-00-1 |
Thromboplastin-D
| 0-01-1 |
Universal Coagulation Reference Plasma
| 1310-73-2 |
4-Fluorobenzoic Acid, 99%
| 456-22-4 |
Eosin Y, 1 % Alcoholic
| 64-17-5 |
Methylsulfuric Acid Sodium Salt (Pract), 99% (Titr.)
| 512-42-5 |
Histomount T
| 108-88-3 |
1-Chloro-2,3-epoxypropane
| 106-89-8 |
2-Chloroethanol
| 107-07-3 |
4-Chloromercuribenzene sulfonic acid, sodium salt
| 14110-97-5 |
4-Chloro-7-nitrobenzofuazan
| 10199-89-0 |
Chloroauric Acid (51 % Au)
| 16903-35-8 |
2-Chlorophenol
| 95-57-8 |
Phenyltrimethylammonium tribromide, 97%
| 4207-56-1 |
4-Chorophenol
| 106-48-9 |
Chlorophenol Red
| 4430-20-0 |
N-Chlorosuccinimide
| 128-09-6 |
4-Chlorotoluene
| 106-43-4 |
Cinnamaldehyde
| 104-55-2 |
Cinnamic Acid
| 621-82-9 |
Citraconic Anhydride
| 616-02-4 |
L-Citrulline
| 372-75-8 |
Cobalt (II) Carbonate
| 12602-23-2 |
2,4,6-Collidine
| 108-75-8 |
Creatine Anhydrous
| 57-00-1 |
Creatinine
| 60-27-5 |
Cresol Mixed Isomers
| 1319-77-3 |
o-Cresolphthaleindi-(methyliminodi-acetic acid)
| 2411-89-4 |
m-Cresol Purple Solution 0.04 %
| 108-39-4 |
Cresol Red Solid
| 1733-12-6 |
Cresol Red Solution 0.02 %
| 64-17-5 |
o-Cresolsulfonphthaleindi-(methyliminodiacetic acid) disodium salt
| 1611-35-4 |
6-Methoxyquinaldine
| 1078-28-0 |
Crotonaldehyde
| 4170-30-3 |
12-Crown-4 ether
| 294-93-9 |
15-Crown-5 Ether
| 33100-27-5 |
18-Crown-6 Ether
| 17455-13-9 |
Copper (II) Acetate
| 142-71-2 |
n-(4-Chloroacetylphenyl)methanesulfonamide , 98% (uv-vis)
| 64488-52-4 |
(2R,3S)-1-Carboxy-4-Propyl-2,3-Dihydroxy-Cyclohexa-4,6-Diene,
| 0-01-1 |
Copper (II) Nitrate
| 3251-23-8 |